8
IRUS Total
Downloads
  Altmetric

Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: a secondary analysis of a randomized single-blind placebo-controlled study

Title: Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: a secondary analysis of a randomized single-blind placebo-controlled study
Authors: Behary, P
Alessimii, H
Miras, AD
Tharakan, G
Alexiadou, K
Aldhwayan, MM
Purkayastha, S
Moorthy, K
Ahmed, AR
Bloom, SR
Tan, TM
Item Type: Journal Article
Abstract: Aims To investigate whether the elevation in postprandial concentrations of the gut hormones glucagon-like peptide-1 (GLP-1), oxyntomodulin (OXM) and peptide YY (PYY) accounts for the beneficial changes in food preferences, sweet taste function and eating behaviour after Roux-en-Y gastric bypass (RYGB). Materials and methods This was a secondary analysis of a randomized single-blind study in which we infused GLP-1, OXM, PYY (GOP) or 0.9% saline subcutaneously for 4 weeks in 24 subjects with obesity and prediabetes/diabetes, to replicate their peak postprandial concentrations, as measured at 1 month in a matched RYGB cohort (ClinicalTrials.gov NCT01945840). A 4-day food diary and validated eating behaviour questionnaires were completed. Sweet taste detection was measured using the method of constant stimuli. Correct sucrose identification (corrected hit rates) was recorded, and sweet taste detection thresholds (EC50s: half maximum effective concencration values) were derived from concentration curves. The intensity and consummatory reward value of sweet taste were assessed using the generalized Labelled Magnitude Scale. Results Mean daily energy intake was reduced by 27% with GOP but no significant changes in food preferences were observed, whereas a reduction in fat and increase in protein intake were seen post-RYGB. There was no change in corrected hit rates or detection thresholds for sucrose detection following GOP infusion. Additionally, GOP did not alter the intensity or consummatory reward value of sweet taste. A significant reduction in restraint eating, comparable to the RYGB group was observed with GOP. Conclusion The elevation in plasma GOP concentrations after RYGB is unlikely to mediate changes in food preferences and sweet taste function after surgery but may promote restraint eating.
Issue Date: Jun-2023
Date of Acceptance: 19-Feb-2023
URI: http://hdl.handle.net/10044/1/104349
DOI: 10.1111/dom.15028
ISSN: 1462-8902
Publisher: Wiley
Start Page: 1731
End Page: 1739
Journal / Book Title: Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics
Volume: 25
Issue: 6
Copyright Statement: © 2023 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Sponsor/Funder: Medical Research Council (MRC)
Funder's Grant Number: MR/K02115X/1
Keywords: Science & Technology
Life Sciences & Biomedicine
Endocrinology & Metabolism
antiobesity drug
bariatric surgery
GLP-1
obesity therapy
randomized trial
weight control
GASTRIC BYPASS-SURGERY
VERTICAL BANDED GASTROPLASTY
GLUCAGON-LIKE PEPTIDE-1
WEIGHT-LOSS
BARIATRIC SURGERY
MORBIDLY OBESE
HEDONIC HUNGER
GLP-1 RESPONSE
BRAIN ACTIVITY
DIETARY-INTAKE
GLP-1
antiobesity drug
bariatric surgery
obesity therapy
randomized trial
weight control
Humans
Taste
Food Preferences
Single-Blind Method
Prediabetic State
Obesity
Gastric Bypass
Gastrointestinal Hormones
Peptide YY
Glucagon-Like Peptide 1
Sucrose
Volunteers
Humans
Prediabetic State
Obesity
Gastrointestinal Hormones
Peptide YY
Sucrose
Gastric Bypass
Single-Blind Method
Food Preferences
Taste
Glucagon-Like Peptide 1
Volunteers
antiobesity drug
bariatric surgery
BARIATRIC SURGERY
BRAIN ACTIVITY
DIETARY-INTAKE
Endocrinology & Metabolism
GASTRIC BYPASS-SURGERY
GLP-1
GLP-1 RESPONSE
GLUCAGON-LIKE PEPTIDE-1
HEDONIC HUNGER
Life Sciences & Biomedicine
MORBIDLY OBESE
obesity therapy
randomized trial
Science & Technology
VERTICAL BANDED GASTROPLASTY
weight control
WEIGHT-LOSS
1103 Clinical Sciences
Endocrinology & Metabolism
Publication Status: Published
Online Publication Date: 2023-02-22
Appears in Collections:Department of Metabolism, Digestion and Reproduction
Department of Surgery and Cancer



This item is licensed under a Creative Commons License Creative Commons